These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17386832)

  • 21. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct; 144(40):49. PubMed ID: 12440300
    [No Abstract]   [Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    Keyhan G; Chen SF; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):594-601. PubMed ID: 17462947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 24. [What is the role of angiotensin receptor antagonists in the treatment of cardiac failure?].
    Komajda M
    Arch Mal Coeur Vaiss; 2001 Apr; 94(4):254-6. PubMed ID: 11387929
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity.
    Kapoor JR
    Am J Cardiol; 2008 Mar; 101(5):744-5. PubMed ID: 18308033
    [No Abstract]   [Full Text] [Related]  

  • 26. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin II-receptor blockers].
    Lommi J
    Duodecim; 2005; 121(6):589-92. PubMed ID: 15907084
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based drug treatment of heart failure.
    Wasson S; Fleming D; Reddy HK
    Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 32. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in response to chronic heart failure therapies.
    Ghali JK; Lindenfeld J
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):555-65. PubMed ID: 18402544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warning on diuretic use.
    Grundtvig M; Westheim A; Hole T; Flønaes B; Gullestad L;
    J Am Coll Cardiol; 2010 Jun; 55(23):2609-10; author reply 2610. PubMed ID: 20513605
    [No Abstract]   [Full Text] [Related]  

  • 35. Ongoing Clinical trials with angiotensin II receptor antagonists in chronic heart failure and myocardial infarction.
    McMurray J; Berry C
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):131-6. PubMed ID: 11967803
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current role of angiotensin II antagonists in the treatment of heart failure].
    Porcu M; Orrù P
    Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296
    [No Abstract]   [Full Text] [Related]  

  • 37. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
    Ditiatkov AE; Tikhonov VA; Radzevich AE
    Probl Tuberk; 2001; (8):37-9. PubMed ID: 11767390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of ARB and ACE inhibitors in heart failure patients.
    Wexler R; Feldman D
    Am Fam Physician; 2009 Mar; 79(6):454; author reply 456. PubMed ID: 19323357
    [No Abstract]   [Full Text] [Related]  

  • 40. [AT1-blocker in heart failure. Patients are readmitted more infrequently to the clinic].
    MMW Fortschr Med; 2000 Nov; 142(48):4-5. PubMed ID: 11144939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.